
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11886894
[patent_doc_number] => 09757441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-12
[patent_title] => 'Anti-Mycoplasma spp. subunit vaccine'
[patent_app_type] => utility
[patent_app_number] => 15/453760
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 4
[patent_no_of_words] => 6612
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15453760
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/453760 | Anti-Mycoplasma spp. subunit vaccine | Mar 7, 2017 | Issued |
Array
(
[id] => 11907096
[patent_doc_number] => 09775893
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Anti-Mycoplasma spp. subunit vaccine'
[patent_app_type] => utility
[patent_app_number] => 15/453691
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 4
[patent_no_of_words] => 6617
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15453691
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/453691 | Anti-Mycoplasma spp. subunit vaccine | Mar 7, 2017 | Issued |
Array
(
[id] => 12165340
[patent_doc_number] => 09884099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection'
[patent_app_type] => utility
[patent_app_number] => 15/450138
[patent_app_country] => US
[patent_app_date] => 2017-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9999
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15450138
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/450138 | Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection | Mar 5, 2017 | Issued |
Array
(
[id] => 14929889
[patent_doc_number] => 20190300582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => MUTANT PORES
[patent_app_type] => utility
[patent_app_number] => 16/081891
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081891
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081891 | Mutant pores | Mar 1, 2017 | Issued |
Array
(
[id] => 16756888
[patent_doc_number] => 10975428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Mutant pore
[patent_app_type] => utility
[patent_app_number] => 16/081894
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 58
[patent_no_of_words] => 58923
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081894 | Mutant pore | Mar 1, 2017 | Issued |
Array
(
[id] => 14929889
[patent_doc_number] => 20190300582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => MUTANT PORES
[patent_app_type] => utility
[patent_app_number] => 16/081891
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081891
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081891 | Mutant pores | Mar 1, 2017 | Issued |
Array
(
[id] => 11914290
[patent_doc_number] => 09782465
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Serologic correlates of protection against Bacillus anthracis infection'
[patent_app_type] => utility
[patent_app_number] => 15/438152
[patent_app_country] => US
[patent_app_date] => 2017-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13499
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15438152
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/438152 | Serologic correlates of protection against Bacillus anthracis infection | Feb 20, 2017 | Issued |
Array
(
[id] => 13899063
[patent_doc_number] => 20190038736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => STREPTOCOCCUS UBERIS EXTRACT AS AN IMMUNOGENIC AGENT
[patent_app_type] => utility
[patent_app_number] => 16/075092
[patent_app_country] => US
[patent_app_date] => 2017-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16075092
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/075092 | None | Feb 13, 2017 | Issued |
Array
(
[id] => 15178711
[patent_doc_number] => 20190359947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => THERAPEUTIC BACTERIOPHAGE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/485408
[patent_app_country] => US
[patent_app_date] => 2017-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485408
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485408 | THERAPEUTIC BACTERIOPHAGE COMPOSITIONS | Feb 12, 2017 | Abandoned |
Array
(
[id] => 17103227
[patent_doc_number] => 11123418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => SLAM polynucleotides and polypeptides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/077112
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 14
[patent_no_of_words] => 18466
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077112
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077112 | SLAM polynucleotides and polypeptides and uses thereof | Feb 9, 2017 | Issued |
Array
(
[id] => 13960103
[patent_doc_number] => 20190056395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => SYSTEMS AND COMPOSITIONS FOR DIAGNOSING PATHOGENIC FUNGAL INFECTION AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/077690
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077690
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077690 | Systems and compositions for diagnosing pathogenic fungal infection and methods of using the same | Feb 9, 2017 | Issued |
Array
(
[id] => 16756604
[patent_doc_number] => 10975141
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Method for the production of immunoglobulin single variable domains
[patent_app_type] => utility
[patent_app_number] => 16/076314
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22143
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076314
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076314 | Method for the production of immunoglobulin single variable domains | Feb 9, 2017 | Issued |
Array
(
[id] => 11650605
[patent_doc_number] => 20170146506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'POTENCY TEST FOR VACCINE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/426206
[patent_app_country] => US
[patent_app_date] => 2017-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5583
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15426206
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/426206 | Potency test for vaccine formulations | Feb 6, 2017 | Issued |
Array
(
[id] => 16213979
[patent_doc_number] => 10729771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-04
[patent_title] => Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of
[patent_app_type] => utility
[patent_app_number] => 16/076971
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 33
[patent_no_of_words] => 30930
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076971
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076971 | Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of | Jan 31, 2017 | Issued |
Array
(
[id] => 11850309
[patent_doc_number] => 20170224801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'NANOPARTICLES FOR TREATMENT OF ALLERGY'
[patent_app_type] => utility
[patent_app_number] => 15/422214
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30280
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15422214
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/422214 | NANOPARTICLES FOR TREATMENT OF ALLERGY | Jan 31, 2017 | Abandoned |
Array
(
[id] => 13899061
[patent_doc_number] => 20190038735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => VLP-BASED VACCINES FOR TARGETING STAPHYLOCOCCUS AUREUS SECRETED VIRULENCE FACTORS
[patent_app_type] => utility
[patent_app_number] => 16/074886
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074886
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074886 | VLP-based vaccines for targeting | Jan 31, 2017 | Issued |
Array
(
[id] => 17140235
[patent_doc_number] => 20210308246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => Modified tetra-acylated neisserial LPS
[patent_app_type] => utility
[patent_app_number] => 16/072510
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16072510
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/072510 | Modified tetra-acylated neisserial LPS | Jan 26, 2017 | Issued |
Array
(
[id] => 14388431
[patent_doc_number] => 10307473
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-04
[patent_title] => Capsular gram-positive bacteria bioconjugate vaccines
[patent_app_type] => utility
[patent_app_number] => 15/414900
[patent_app_country] => US
[patent_app_date] => 2017-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 46
[patent_no_of_words] => 33181
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15414900
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/414900 | Capsular gram-positive bacteria bioconjugate vaccines | Jan 24, 2017 | Issued |
Array
(
[id] => 11625901
[patent_doc_number] => 20170136090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'Angiopoietin-Based Interventions for Treating Cerebral Malaria'
[patent_app_type] => utility
[patent_app_number] => 15/414925
[patent_app_country] => US
[patent_app_date] => 2017-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 9149
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15414925
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/414925 | Angiopoietin-based interventions for treating cerebral malaria | Jan 24, 2017 | Issued |
Array
(
[id] => 13899013
[patent_doc_number] => 20190038711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => Medicament For Treating Pulmonary Tuberculosis
[patent_app_type] => utility
[patent_app_number] => 16/073887
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073887
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073887 | Medicament for treating pulmonary tuberculosis | Jan 19, 2017 | Issued |